Endocan
Biomarker1 paper2 findings
- Human trial1
Interventions
2Rosuvastatin
downin humans1
1 study
Rosuvastatin
downin humans1
Rosuvastatin decreases endocan in humans.
“Atorvastatin and rosuvastatin therapies significantly decreased plasma concentrations of both endocan and endoglin”
Humansprimary cardiovascular preventionplasmaup to 16 weeksfemales
The Influence of Statin Therapy on Markers of Endothelial Dysfunction, Endocan and Endoglin, in Postmenopausal Women-A Prospective Study · Biomedicines · 27 Aug 2026
Atorvastatin
downin humans1
1 study
Atorvastatin
downin humans1
Atorvastatin decreases endocan in humans.
“Atorvastatin and rosuvastatin therapies significantly decreased plasma concentrations of both endocan and endoglin”
Humansprimary cardiovascular preventionplasmaup to 16 weeksfemales
The Influence of Statin Therapy on Markers of Endothelial Dysfunction, Endocan and Endoglin, in Postmenopausal Women-A Prospective Study · Biomedicines · 27 Aug 2026